Argenx Se (ARGX) Shares Outstanding (2015 - 2026)
Argenx Se's (ARGX) quarterly Shares Outstanding (Entity) came in at $61.9 million in Q4 2025, up 1.85% on a YoY basis from $60.8 million in Q4 2024, and up 1.85% quarter-over-quarter from $60.8 million in Q4 2024.
Argenx Se (ARGX) Shares Outstanding (2015 - 2026) Analysis & Trends
Argenx Se (ARGX) has reported Shares Outstanding (Entity) for 11 consecutive years, with $61.9 million the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Shares Outstanding (Entity) rose 1.85% year-over-year to $61.9 million; the trailing twelve-month figure through Dec 2025 stood at $61.9 million (up 1.85% YoY), and the FY2025 full-year result was $61.9 million, up 1.85% from the prior year.
- Shares Outstanding (Entity) advanced to $61.9 million in Q4 2025 per ARGX's latest filing, from $60.8 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $61.9 million in Q4 2025 and bottomed at $51.7 million in Q4 2021.
- Historically, Shares Outstanding (Entity) has averaged $57.8 million across 5 years, with a median of $59.2 million in 2023.
- The sharpest annual moves came in 2021 and 2025: Shares Outstanding (Entity) climbed 8.61% in 2021, then climbed 1.85% in 2025.
- Over 5 years, Shares Outstanding (Entity) stood at $51.7 million in 2021, then rose by 7.21% to $55.4 million in 2022, then increased by 6.86% to $59.2 million in 2023, then gained by 2.65% to $60.8 million in 2024, then advanced by 1.85% to $61.9 million in 2025.
- According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $61.9 million, $60.8 million, and $59.2 million for Q4 2025, Q4 2024, and Q4 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | 1.94 Bn |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | 1.55 Bn |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | 540.00 Mn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | 253.70 Mn |
| 10 | Argenx Se | 58.53 Bn | 53.35 Bn | 1.37 Bn | 61.30 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 61.30 Mn |
| Mar 31, 2026 | 61.30 Mn |
| Dec 31, 2025 | 61.30 Mn |
| Sep 30, 2025 | 59.86 Mn |
| Jun 30, 2025 | 59.86 Mn |
| Mar 31, 2025 | 59.86 Mn |
| Dec 31, 2024 | 59.86 Mn |
| Sep 30, 2024 | 57.17 Mn |
| Jun 30, 2024 | 57.17 Mn |
| Mar 31, 2024 | 57.17 Mn |
| Dec 31, 2023 | 57.17 Mn |
| Sep 30, 2023 | 54.38 Mn |
| Jun 30, 2023 | 54.38 Mn |
| Mar 31, 2023 | 54.38 Mn |
| Dec 31, 2022 | 54.38 Mn |
| Sep 30, 2022 | 51.08 Mn |
| Jun 30, 2022 | 51.08 Mn |
| Mar 31, 2022 | 51.08 Mn |
| Dec 31, 2021 | 51.08 Mn |
| Sep 30, 2021 | 45.41 Mn |
Argenx Se Shares Outstanding API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding&ticker=ARGX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding", "ticker": "ARGX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding&ticker=ARGX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();